Related Experiment Video
Updated: Aug 16, 2026

Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
Published on: February 22, 2015
Conditionally MYC: insights from novel transgenic models
Constadina Arvanitis1, Dean W Felsher
1Departments of Medicine and Pathology, Division of Oncology, School of Medicine, Stanford University, CCSR 1105B, 269 Campus Drive, Stanford, CA 94305-5151, USA.
Abstract:
MYC was one of the first oncogenes identified to be associated with chromosomal aberrations and one of the most common oncogenes involved in the pathogenesis of cancer. However, until recently it was not clear if MYC would be a good target for the treatment of cancer. New conditional transgenic models have been used to demonstrate that even the brief inactivation of MYC can reverse tumorigenesis. Here we review results from recent experimental model systems, which demonstrate that the inactivation of MYC may be a specific and effective treatment for many types of cancer.
Insights
MYC oncogene inactivation can reverse cancer development. Recent studies show targeting MYC offers a promising and effective cancer treatment strategy across various cancer types.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MYC is a well-known oncogene implicated in numerous cancers.
- Its role in cancer pathogenesis has been recognized for decades.
- The therapeutic potential of targeting MYC remained uncertain until recently.
Purpose of the Study:
- To review experimental evidence on MYC inactivation as a cancer therapy.
- To assess the efficacy and specificity of targeting MYC.
Main Methods:
- Review of recent experimental model systems.
- Analysis of data from conditional transgenic models demonstrating MYC inactivation.
Main Results:
- Brief inactivation of MYC can lead to the reversal of established tumorigenesis.
- Experimental models show MYC inactivation is feasible and effective.
Conclusions:
- Targeting MYC represents a specific and effective therapeutic strategy for many cancers.
- Further research into MYC-targeted therapies is warranted.
More Related Videos
09:45Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis
Published on: March 31, 2015
10:31The Drosophila Imaginal Disc Tumor Model: Visualization and Quantification of Gene Expression and Tumor Invasiveness Using Genetic Mosaics
Published on: October 6, 2016
Related Concept Videos
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Transgenic Organisms
In-vitro Mutagenesis